cancer risk with semaglutide Can obesity meds also reduce risk? A retrospective study of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked GLP-1 use linked to better
Description
Our findings support an association between use of semaglutide for type 2 diabetes and risk of non-arteritic anterior ischemic optic neuropathy, with a more than two-fold increased hazard ratio, Professor Pottegrd explained
Fuel Whats Next
At the examined Greek thresholds of 27,117 or 34,000 per QALY, semaglutide was cost-effective vs
This education includes understanding possible drug interactions, recognizing contraindications, and knowing when to seek medical advice
Journal of the American College of Cardiology, 72(22), 27612777
